Abstract:Drugs and chemotherapeutics have helped to manage devastating impacts of infectious diseases since the concept of 'magic bullet'. The World Health Organization estimates about 650,000 deaths due to respiratory diseases linked to seasonal influenza each year. Pandemic influenza, on the other hand, is the most feared health disaster and probably would have greater and immediate impact on humanity than climate change. While countermeasures, biosecurity and vaccination remain the most effective preventive strategies against this highly infectious and communicable disease, antivirals are nonetheless essential to mitigate clinical manifestations following infection and to reduce devastating complications and mortality. Continuous emergence of the novel strains of rapidly evolving influenza viruses, some of which are intractable, require new approaches towards influenza chemotherapeutics including optimization of existing anti-infectives and search for novel therapies. Effective management of influenza infections depend on the safety and efficacy of selected anti-infective in-vitro studies and their clinical applications. The outcomes of therapies are also dependent on understanding diversity in patient groups, co-morbidities, co-infections and combination therapies. In this extensive review, we have discussed the challenges of influenza epidemics and pandemics and discoursed the options for anti-viral chemotherapies for effective management of influenza virus infections.

Progress of Influenza Viruses and Inhibitors

Research Progress on Drug-Resistance of Influenza Virus to Neuraminidase Inhibitors

The Development History, Structural Composition, and Functions of Influenza Viruses and the Progress of Influenza Virus Inhibitors in Clinics and Clinical Trials

Progress Of Small Molecular Inhibitors In The Development Of Anti-Influenza Virus Agents

Development and Effects of Influenza Antiviral Drugs

Targets for Anti-Influenza Virus Agents: Research Advances

Emerging antiviral therapies and drugs for the treatment of influenza

History and Reflection of Pandemic Influenza

Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs"

Potential targets and their relevant inhibitors in anti-influenza fields.

Research Progress of Anti-Influenza Virus Agents

Influenza B Virus: Target and Acting Mechanism of Antiviral Drugs

Recent Progress of Novel Anti-Influenza Entry Inhibitors

Influenza Virus Cell Entry and Targeted Antiviral Development

Progress on 2009 H1N1 Virus and Prevention and Treatment of Influenza Pandemic

Antiviral options and therapeutics against influenza: history, latest developments and future prospects

Emerging Drug Design Strategies in Anti-Influenza Drug Discovery

Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance

Recent Advances of Phenotypic Screening Strategies in the Application of Anti-Influenza Virus Drug Discovery

Advances in Anti-Influenza Drugs: Neuraminidase Inhibitors

A brief review of influenza virus infection